Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
2,036
Views
0
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses

In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

Ami Patela Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Kyle Rosenkeb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Elizabeth M. Parzycha Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Friederike Feldmannb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Suman Bhartia Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Amanda J. Griffinb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Blake Schouestc Inovio Pharmaceuticals, Plymouth Meeting, PA, USAView further author information
,
Matt Lewisb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Jihae Choia Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Neethu Chokkalingama Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Viviane Machadoc Inovio Pharmaceuticals, Plymouth Meeting, PA, USAView further author information
,
Brian J. Smithb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Drew Frasea Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Ali R. Alia Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Jamie Lovagliob Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Brian Nguyenc Inovio Pharmaceuticals, Plymouth Meeting, PA, USAView further author information
,
Patrick W. Hanleyb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAView further author information
,
Susanne N. Walkera Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Ebony N. Garya Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Abhijeet Kulkarnia Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Allison Generottic Inovio Pharmaceuticals, Plymouth Meeting, PA, USAView further author information
,
Joseph R. Francicad Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Kim Rosenthald Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Daniel W. Kulpa Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USAView further author information
,
Mark T. Esserd Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Trevor R. F. Smithc Inovio Pharmaceuticals, Plymouth Meeting, PA, USAView further author information
,
Carl Shaiab Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAORCID Iconhttps://orcid.org/0000-0001-8907-8821View further author information
ORCID Icon,
David B. Weinera Vaccine and Immunotherapy Center, The Wistar Institute of Anatomy and Biology, Philadelphia, PA, USACorrespondence[email protected]
View further author information
&
Heinz Feldmannb Rocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USAORCID Iconhttps://orcid.org/0000-0001-9448-8227View further author information
ORCID Icon show all
Article: 2294860 | Received 11 Jul 2023, Accepted 11 Dec 2023, Published online: 28 Feb 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.